文献速递临床试验与 GCP

中药治疗糖尿病肾病随机对照试验的研究方案

Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-07-17

该文报告一项多中心随机对照试验方案,纳入266例糖尿病肾病患者(早期106例、中期80例、晚期80例),按1:1随机分配至消疹方联合基础治疗组或单纯基础治疗组,疗程24周,主要结局分别为尿微量白蛋白排泄率、24小时尿蛋白和eGFR,同时评估不良事件。

要点

  • 中药消疹方联合基础治疗用于糖尿病肾病各期患者。
  • 主要结局按分期设定:早期尿微量白蛋白排泄率、中期24小时尿蛋白、晚期eGFR。
  • 研究为多中心随机对照试验,样本量266例,疗程24周。

核心结论

  • 该研究将为中药治疗糖尿病肾病的有效性和安全性提供证据。

研究设计与样本

  • 多中心随机对照试验,纳入266例糖尿病肾病患者,其中早期106例、中期80例、晚期80例,eGFR≥30 mL/min/1.73m2。
  • 各期患者按1:1比例随机分配至消疹方联合基础治疗组或单纯基础治疗组,研究时长24周。

关键数值与推荐

  • 主要结局:早期糖尿病肾病为尿微量白蛋白排泄率,中期为24小时尿蛋白,晚期为eGFR。
  • 所有结局指标在基线及第4、12、24周收集数据,并评估不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic kidney disease (DKD) is a major microvascular complication of diabetes mellitus and the primary cause of end-stage renal disease. Existing therapies for DKD are not sufficiently effective. We report the protocol of a pragmatic randomized controlled trial of the use of traditional Chinese herbal medicine to treat patients with DKD. METHODS/DESIGN: This will be a multicenter randomized controlled trial. A total of 266 patients with DKD (106 with early stage, 80 with middle-stage, and 80 with advanced-stage disease) with an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73m2will be included. Participants with DKD of each stage will be randomly allocated at a 1:1 ratio to either the experimental group, which will receive Xiaozhen formula and basic treatment, or the control group, which will receive basic treatment only. The study duration will be 24 weeks. The primary outcome will be urinary microalbumin excretion rate for early stage DKD, 24-h urinary protein for middle-stage DKD, and eGFR for advanced-stage DKD. Adverse events will also be evaluated. Data for all outcome indicators will be collected at baseline and weeks 4, 12, and 24. DISCUSSION: This study will provide evidence of the effectiveness and safety of traditional Chinese herbal medicine in treating patients with DKD. TRIAL REGISTRATION: Chinese Clinical Trials Registry: ChiCTR-IOR-16010072 . Registered on 2 December 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang M, Wang Z, Zhou J, et al. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30016983. doi:10.1186/s13063-018-2749-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。